Pancreatic Cancer UK has warned shortages of the drug Creon could last until at least 2026, affecting an estimated 61,152 people. Creon is the most popular brand of pancreatic enzyme replacement ...

Cancer patients and others with debilitating conditions have highlighted shortages of a vital drug they say have had a "devastating" impact on their lives. Creon, a pancreatic enzyme replacement ...

Creon Butler leads the Global Economy and Finance Programme at Chatham House. He joined the institute in 2019, since when he has written and published on a wide range of global economic policy issues, ...

Wes Streeting says he is "extremely sorry" patients who need medication for pancreatic insufficiency are being affected by shortages. The health secretary said global supply chain issues were ...

Mick needs creon since being treated for pancreatic cancer in 2023 Cancer patients and others with debilitating conditions have highlighted shortages of a vital drug they say have had a ...

Creon Butler joined Chatham House from the Cabinet Office where he served as director for international economic affairs in the National Security Secretariat and G7/G20 ‘sous sherpa’, advising on ...

Pancreatic Cancer UK has warned shortages of the drug Creon could last until at least 2026, affecting an estimated 61,152 people. But what is Creon, what does it treat and how is the shortage ...

Creon, a pancreatic enzyme replacement therapy (Pert), helps digestion, but has been hard to obtain for the last year and shortages are predicted to last until 2026. It is thought more than 61,000 ...

Creon, a pancreatic enzyme replacement therapy (Pert), helps digestion, but has been hard to obtain for the last year and shortages are predicted to last until 2026. It is thought more than 61,000 ...

As the region faces a measles outbreak, Dr. Adelle Chang On has stepped in as the Grand Erie Public Health's (GEPH) new acting medical officer of health.The health unit, which encompasses the counties ...